Literature DB >> 21764586

Prominent brainstem symptoms/signs in patients with neuromyelitis optica in a Taiwanese population.

Kai-Chen Wang1, Chao-Lin Lee, Shao-Yuan Chen, Kuan-Hsiang Lin, Ching-Piao Tsai.   

Abstract

Neuromyelitis optica (NMO) is a severe demyelinating disease defined principally by its selective effect on the optic nerves and spinal cord. Contemporary diagnostic criteria require an absence of any clinical disease outside the optic nerve or spinal cord. However, we frequently encounter patients with NMO who have previously undetected symptomatic brainstem lesions. We investigated the brainstem symptoms/signs in patients with NMO and their corresponding MRI findings in a Taiwanese population. We evaluated the clinical symptoms/signs, anti-aquaporin-4 antibody titer and corresponding brain MRI of 49 patients with NMO; results were obtained from chart reviews and during clinical visits. A total of 18 (37%) patients with NMO had brainstem symptoms/signs, including diplopia (n=9, 50%), prolonged hiccup and poor appetite (n=9, 50%). For these patients, most of their brainstem events occurred during the first demyelinating attack in their NMO course. A higher percentage (77.8%) of patients with brainstem NMO had brain lesions with specific NMO patterns, including lesions involving the hypothalamus (n=6, 33.3%), midbrain or pons (n=8, 44.4%), periaqueductal regions (n=5, 27.7%), and medulla (n=10, 55.6%). Brainstem symptoms/signs and characteristic NMO imaging findings are common in Taiwanese patients with NMO, and should be considered a part of the illness in addition to optic neuritis and myelitis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764586     DOI: 10.1016/j.jocn.2010.12.052

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  Comparative clinical characteristics of neuromyelitis optica spectrum disorders with and without medulla oblongata lesions.

Authors:  Yanqiang Wang; Lei Zhang; Bingjun Zhang; Yongqiang Dai; Zhuang Kang; Ciyong Lu; Wei Qiu; Xueqiang Hu; Zhengqi Lu
Journal:  J Neurol       Date:  2014-03-09       Impact factor: 4.849

2.  Hiccup: mystery, nature and treatment.

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

3.  Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.

Authors:  Ming-Feng Liao; Kuo-Hsuan Chang; Rong-Kuo Lyu; Chin-Chang Huang; Hong-Shiu Chang; Yih-Ru Wu; Chiung-Mei Chen; Chun-Che Chu; Hung-Chou Kuo; Long-Sun Ro
Journal:  BMC Neurol       Date:  2014-11-30       Impact factor: 2.474

4.  The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica.

Authors:  Chen Cheng; Ying Jiang; Xiaodong Lu; Fu Gu; Zhuang Kang; Yongqiang Dai; Zhengqi Lu; Xueqiang Hu
Journal:  BMC Neurol       Date:  2016-10-21       Impact factor: 2.474

5.  Different Phenotypes at Onset in Neuromyelitis Optica Spectrum Disorder Patients with Aquaporin-4 Autoimmunity.

Authors:  Youming Long; Junyan Liang; Linzhan Wu; Shaopeng Lin; Cong Gao; Xiaohui Chen; Wei Qiu; Yu Yang; Xueping Zheng; Ning Yang; Min Gao; Yaotang Chen; Zhanhang Wang; Quanxi Su
Journal:  Front Neurol       Date:  2017-02-28       Impact factor: 4.003

Review 6.  Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Authors:  Nadja Borisow; Masahiro Mori; Satoshi Kuwabara; Michael Scheel; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-23       Impact factor: 4.003

7.  Acute proximal left anterior descending thrombosis manifested by persistent hiccups: A case report.

Authors:  Hanxiang Gao; Bo Zhang; Li Song; Suyu Yao; Zheng Zhang; Ming Bai
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Clinical and prognostic aspects of patients with the Neuromyelitis Optica Spectrum Disorder (NMOSD) from a cohort in Northeast Brazil.

Authors:  Thiago Gonçalves Fukuda; Ivã Taiuan Fialho Silva; Tayla Samanta Silva Dos Santos; Marcos Baruch Portela Filho; Fernanda Ferreira de Abreu; Jamary Oliveira-Filho
Journal:  BMC Neurol       Date:  2022-03-16       Impact factor: 2.474

9.  A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.

Authors:  Davood Kashipazha; Seyed Ehsan Mohammadianinejad; Nastaran Majdinasab; Mostafa Azizi; Majid Jafari
Journal:  Iran J Neurol       Date:  2015-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.